A Database For The Collection Of Clinical, Laboratory, And Treatment Data From Patients With Factor X Deficiency To Define The Natural History Of The Disease And Improve Patient Management
Condition(s) studied
Study summary
Factor X deficiency is one of the most severe rare bleeding disorders and may lead to serious spontaneous hemorrhages, particularly in patients with severe congenital forms. Acquired FX deficiency is even rarer, most frequently associated with AL amyloidosis, and remains poorly characterized. Establishing a comprehensive patient registry is essential to improve understanding of disease epidemiology, clinical manifestations, and treatment outcomes, ultimately supporting evidence-based management strategies.
Eligibility
Primary outcome measure(s)
- Bleedings — 3 years
To estimate total bleed rates including major, minor, spontaneous and non-spontaneous episodes in patients with FX deficiency
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Azienda Ospedaliero Universitaria Careggi. SODc Malattie Emorragiche e della Coagulazione | Florence | Italy | Recruiting |
| Angelo Bianchi Bonomi, Hemophilia and Thrombosis Center | Milan | Italy | Recruiting |
More Fondazione Luigi Villa trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07875478 on ClinicalTrials.gov ↗ ← All trials in Italy